{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:23Z","timestamp":1792787843003,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-026-03850-9","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:54:43Z","timestamp":1769514883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Maternal cariprazine exposure effects on lactating offspring sterol biosynthesis"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3511-939X","authenticated-orcid":false,"given":"Allison C.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8690-4507","authenticated-orcid":false,"given":"\u017deljka","family":"Korade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5521-0254","authenticated-orcid":false,"given":"K\u00e1roly","family":"Mirnics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"3850_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/00041433-200104000-00003","volume":"12","author":"JM Dietschy","year":"2001","unstructured":"Dietschy JM, Turley SD. Cholesterol metabolism in the brain. Curr Opin Lipidol. 2001;12:105\u201312.","journal-title":"Curr Opin Lipidol"},{"key":"3850_CR2","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","volume":"45","author":"JM Dietschy","year":"2004","unstructured":"Dietschy JM, Turley SD. Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res. 2004;45:1375\u201397.","journal-title":"J Lipid Res"},{"key":"3850_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.723224","volume":"12","author":"WJ Griffiths","year":"2021","unstructured":"Griffiths WJ, Wang Y. Sterols, oxysterols, and accessible cholesterol: signalling for homeostasis, in immunity and during development. Front Physiol. 2021;12:723224.","journal-title":"Front Physiol"},{"key":"3850_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2021.100165","volume":"63","author":"WJ Griffiths","year":"2022","unstructured":"Griffiths WJ, Wang Y. Cholesterol metabolism: from lipidomics to immunology. J Lipid Res. 2022;63:100165.","journal-title":"J Lipid Res"},{"key":"3850_CR5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/ejhg.2008.10","volume":"16","author":"FD Porter","year":"2008","unstructured":"Porter FD. Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management. Eur J Hum Genet. 2008;16:535\u201341.","journal-title":"Eur J Hum Genet"},{"key":"3850_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1194\/jlr.R009548","volume":"52","author":"FD Porter","year":"2011","unstructured":"Porter FD, Herman GE. Malformation syndromes caused by disorders of cholesterol synthesis. J Lipid Res. 2011;52:6\u201334.","journal-title":"J Lipid Res"},{"key":"3850_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3390\/biom14040410","volume":"14","author":"ES Peeples","year":"2024","unstructured":"Peeples ES, Mirnics K, Korade Z. Chemical inhibition of sterol biosynthesis. Biomolecules. 2024;14:410.","journal-title":"Biomolecules"},{"key":"3850_CR8","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3390\/biom12091211","volume":"12","author":"LB Allen","year":"2022","unstructured":"Allen LB, Mirnics K. Metoprolol inhibits developmental brain sterol biosynthesis in mice. Biomolecules. 2022;12:1211.","journal-title":"Biomolecules"},{"key":"3850_CR9","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1021\/acsptsci.1c00012","volume":"4","author":"TC Genaro-Mattos","year":"2021","unstructured":"Genaro-Mattos TC, Klingelsmith KB, Allen LB, Anderson A, Tallman KA, Porter NA, et al. Sterol biosynthesis inhibition in pregnant women taking prescription medications. ACS Pharmacol Transl Sci. 2021;4:848\u201357.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"3850_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01217-w","volume":"11","author":"Z Korade","year":"2021","unstructured":"Korade Z, Allen LB, Anderson A, Tallman KA, Genaro-Mattos TC, Porter NA, et al. Trazodone effects on developing brain. Transl Psychiatry. 2021;11:85.","journal-title":"Transl Psychiatry"},{"key":"3850_CR11","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3390\/biom13091321","volume":"13","author":"Z Korade","year":"2023","unstructured":"Korade Z, Anderson A, Balog M, Tallman KA, Porter NA, Mirnics K. Chronic aripiprazole and trazodone polypharmacy effects on systemic and brain cholesterol biosynthesis. Biomolecules. 2023;13:1321.","journal-title":"Biomolecules"},{"key":"3850_CR12","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3390\/biom15040562","volume":"15","author":"Z Korade","year":"2025","unstructured":"Korade Z, Anderson AC, Balog M, Tallman KA, Porter NA, Mirnics K. Hydroxyzine effects on post-lanosterol biosynthesis in smith-lemli-opitz syndrome (SLOS) models. Biomolecules. 2025;15:562.","journal-title":"Biomolecules"},{"key":"3850_CR13","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1194\/jlr.M079475","volume":"58","author":"Z Korade","year":"2017","unstructured":"Korade Z, Genaro-Mattos TC, Tallman KA, Liu W, Garbett KA, Koczok K, et al. Vulnerability of DHCR7(+\/-) mutation carriers to aripiprazole and trazodone exposure. J Lipid Res. 2017;58:2139\u201346.","journal-title":"J Lipid Res"},{"key":"3850_CR14","unstructured":"FDA. Cariprazine prescribing information 2015 [Reference ID: 3821760]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/204370lbl.pdf."},{"key":"3850_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.schres.2024.03.038","volume":"267","author":"J Lyne","year":"2024","unstructured":"Lyne J, Piacenza F, Radovic J, O\u2019Donoghue B. The effectiveness of adjunctive cariprazine for treatment of negative symptoms: a systematic review of randomised controlled trials. Schizophr Res. 2024;267:213\u20135.","journal-title":"Schizophr Res"},{"key":"3850_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.taap.2018.04.029","volume":"349","author":"TC Genaro-Mattos","year":"2018","unstructured":"Genaro-Mattos TC, Tallman KA, Allen LB, Anderson A, Mirnics K, Korade Z, et al. Dichlorophenyl piperazines, including a recently-approved atypical antipsychotic, are potent inhibitors of DHCR7, the last enzyme in cholesterol biosynthesis. Toxicol Appl Pharmacol. 2018;349:21\u20138.","journal-title":"Toxicol Appl Pharmacol"},{"key":"3850_CR17","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1021\/acschemneuro.0c00765","volume":"12","author":"KA Tallman","year":"2021","unstructured":"Tallman KA, Allen LB, Klingelsmith K, Anderson A, Genaro-Mattos TC, Mirnics K, et al. Prescription medications alter neuronal and glial cholesterol synthesis. ACS Chem Neurosci. 2021;12:735\u201345.","journal-title":"ACS Chem Neurosci"},{"key":"3850_CR18","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1073\/pnas.95.4.1899","volume":"95","author":"FF Moebius","year":"1998","unstructured":"Moebius FF, Fitzky BU, Lee JN, Paik YK, Glossmann H. Molecular cloning and expression of the human delta7-sterol reductase. Proc Natl Acad Sci USA. 1998;95:1899\u2013902.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3850_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1086\/301936","volume":"63","author":"CA Wassif","year":"1998","unstructured":"Wassif CA, Maslen C, Kachilele-Linjewile S, Lin D, Linck LM, Connor WE, et al. Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome. Am J Hum Genet. 1998;63:55\u201362.","journal-title":"Am J Hum Genet"},{"key":"3850_CR20","doi-asserted-by":"publisher","first-page":"8181","DOI":"10.1073\/pnas.95.14.8181","volume":"95","author":"BU Fitzky","year":"1998","unstructured":"Fitzky BU, Witsch-Baumgartner M, Erdel M, Lee JN, Paik YK, Glossmann H, et al. Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc Natl Acad Sci USA. 1998;95:8181\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3850_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJM199401133300205","volume":"330","author":"GS Tint","year":"1994","unstructured":"Tint GS, Irons M, Elias ER, Batta AK, Frieden R, Chen TS, et al. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med. 1994;330:107\u201313.","journal-title":"N Engl J Med"},{"key":"3850_CR22","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1093\/hmg\/10.6.555","volume":"10","author":"CA Wassif","year":"2001","unstructured":"Wassif CA, Zhu P, Kratz L, Krakowiak PA, Battaile KP, Weight FF, et al. Biochemical, phenotypic and neurophysiological characterization of a genetic mouse model of RSH\/Smith-Lemli-Opitz syndrome. Hum Mol Genet. 2001;10:555\u201364.","journal-title":"Hum Mol Genet"},{"key":"3850_CR23","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1038\/s41380-020-0801-x","volume":"25","author":"TC Genaro-Mattos","year":"2020","unstructured":"Genaro-Mattos TC, Anderson A, Allen LB, Tallman KA, Porter NA, Korade Z, et al. Maternal cariprazine exposure inhibits embryonic and postnatal brain cholesterol biosynthesis. Mol Psychiatry. 2020;25:2685\u201394.","journal-title":"Mol Psychiatry"},{"key":"3850_CR24","unstructured":"Krutsch K Cariprazine induced adverse effects in breastfed infants? Texas Tech University: The InfantRisk Center; 2021 https:\/\/www.infantrisk.com\/content\/cariprazine-induced-adverse-effects-breastfed-infants."},{"key":"3850_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/10398562231159510","volume":"31","author":"S Naughton","year":"2023","unstructured":"Naughton S, O\u2019Hara K, Nelson J, Keightley P. Aripiprazole, brexpiprazole, and cariprazine can affect milk supply: advice to breastfeeding mothers. Australas Psychiatry. 2023;31:201\u20134.","journal-title":"Australas Psychiatry"},{"key":"3850_CR26","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1086\/301982","volume":"63","author":"HR Waterham","year":"1998","unstructured":"Waterham HR, Wijburg FA, Hennekam RC, Vreken P, Poll-The BT, Dorland L, et al. Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene. Am J Hum Genet. 1998;63:329\u201338.","journal-title":"Am J Hum Genet"},{"key":"3850_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7:27\u201331.","journal-title":"J Basic Clin Pharm"},{"key":"3850_CR28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41392-022-01125-5","volume":"7","author":"Y Duan","year":"2022","unstructured":"Duan Y, Gong K, Xu S, Zhang F, Meng X, Han J. Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics. Signal Transduct Target Ther. 2022;7:265.","journal-title":"Signal Transduct Target Ther"},{"key":"3850_CR29","doi-asserted-by":"publisher","first-page":"554","DOI":"10.5607\/en.2019.28.5.554","volume":"28","author":"U Jin","year":"2019","unstructured":"Jin U, Park SJ, Park SM. Cholesterol metabolism in the brain and its association with parkinson\u2019s disease. Exp Neurobiol. 2019;28:554\u201367.","journal-title":"Exp Neurobiol"},{"key":"3850_CR30","doi-asserted-by":"publisher","first-page":"219683","DOI":"10.1155\/2010\/219683","volume":"2010","author":"RM Uranga","year":"2010","unstructured":"Uranga RM, Keller JN. Diet and age interactions with regards to cholesterol regulation and brain pathogenesis. Curr Gerontol Geriatr Res. 2010;2010:219683.","journal-title":"Curr Gerontol Geriatr Res"},{"key":"3850_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.37349\/ent.2022.00015","volume":"2","author":"L Qian","year":"2022","unstructured":"Qian L, Chai AB, Gelissen IC, Brown AJ. Balancing cholesterol in the brain: from synthesis to disposal. Exploration of Neuroprotective Therapy. 2022;2:1\u201327.","journal-title":"Exploration of Neuroprotective Therapy"},{"key":"3850_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1021635826032","volume":"28","author":"S Ando","year":"2003","unstructured":"Ando S, Tanaka Y, Toyoda Y, Kon K. Turnover of myelin lipids in aging brain. Neurochem Res. 2003;28:5\u201313.","journal-title":"Neurochem Res"},{"key":"3850_CR33","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/S0022-2275(20)32188-X","volume":"39","author":"I Bjorkhem","year":"1998","unstructured":"Bjorkhem I, Lutjohann D, Diczfalusy U, Stahle L, Ahlborg G, Wahren J. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res. 1998;39:1594\u2013600.","journal-title":"J Lipid Res"},{"key":"3850_CR34","doi-asserted-by":"publisher","first-page":"6423","DOI":"10.1021\/cr200021m","volume":"111","author":"WD Nes","year":"2011","unstructured":"Nes WD. Biosynthesis of cholesterol and other sterols. Chem Rev. 2011;111:6423\u201351.","journal-title":"Chem Rev"},{"key":"3850_CR35","unstructured":"FDA. FDA Drug Safety Communication: Antipsychotic drug labels updated on use during pregnancy and risk of abnormal muscle movements and withdrawal symptoms in newborns 2017 https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-antipsychotic-drug-labels-updated-use-during-pregnancy-and-risk#:~:text=Healthcare%20professionals%20should%20be%20aware,may%20require%20longer%20hospital%20stays."},{"key":"3850_CR36","doi-asserted-by":"publisher","first-page":"S303","DOI":"10.4103\/0019-5545.161497","volume":"57","author":"GN Babu","year":"2015","unstructured":"Babu GN, Desai G, Chandra PS. Antipsychotics in pregnancy and lactation. Indian J Psychiatry. 2015;57:S303\u20137.","journal-title":"Indian J Psychiatry"},{"key":"3850_CR37","doi-asserted-by":"publisher","first-page":"13037","DOI":"10.1021\/ja9029076","volume":"131","author":"L Xu","year":"2009","unstructured":"Xu L, Davis TA, Porter NA. Rate constants for peroxidation of polyunsaturated fatty acids and sterols in solution and in liposomes. J Am Chem Soc. 2009;131:13037\u201344.","journal-title":"J Am Chem Soc"},{"key":"3850_CR38","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3109\/10715762.2014.985219","volume":"49","author":"L Xu","year":"2015","unstructured":"Xu L, Porter NA. Free radical oxidation of cholesterol and its precursors: Implications in cholesterol biosynthesis disorders. Free Radic Res. 2015;49:835\u201349.","journal-title":"Free Radic Res"},{"key":"3850_CR39","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1194\/jlr.M035733","volume":"54","author":"L Xu","year":"2013","unstructured":"Xu L, Korade Z, Rosado DA Jr., Mirnics K, Porter NA. Metabolism of oxysterols derived from nonenzymatic oxidation of 7-dehydrocholesterol in cells. J Lipid Res. 2013;54:1135\u201343.","journal-title":"J Lipid Res"},{"key":"3850_CR40","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1194\/jlr.M018366","volume":"52","author":"L Xu","year":"2011","unstructured":"Xu L, Liu W, Sheflin LG, Fliesler SJ, Porter NA. Novel oxysterols observed in tissues and fluids of AY9944-treated rats: a model for Smith-Lemli-Opitz syndrome. J Lipid Res. 2011;52:1810\u201320.","journal-title":"J Lipid Res"},{"key":"3850_CR41","unstructured":"Administration USFaD. Vraylar (cariprazine): Clinical pharmacology and biopharmaceutics review(s): Center for Drug Evaluation and Research; 2015 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2015\/204370Orig1Orig2s000MedR.pdf."},{"key":"3850_CR42","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1124\/jpet.109.160432","volume":"333","author":"B Kiss","year":"2010","unstructured":"Kiss B, Horvath A, Nemethy Z, Schmidt E, Laszlovszky I, Bugovics G, et al. Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)\/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile. J Pharmacol Exp Ther. 2010;333:328\u201340.","journal-title":"J Pharmacol Exp Ther"},{"key":"3850_CR43","doi-asserted-by":"publisher","first-page":"5490","DOI":"10.1021\/acsomega.0c05817","volume":"6","author":"TC Genaro-Mattos","year":"2021","unstructured":"Genaro-Mattos TC, Anderson A, Allen LB, Korade Z, Mirnics K. Altered cholesterol biosynthesis affects drug metabolism. ACS Omega. 2021;6:5490\u20138.","journal-title":"ACS Omega"},{"key":"3850_CR44","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1017\/S1092852913000680","volume":"19","author":"YK Choi","year":"2014","unstructured":"Choi YK, Adham N, Kiss B, Gyertyan I, Tarazi FI. Long-term effects of cariprazine exposure on dopamine receptor subtypes. CNS Spectr. 2014;19:268\u201377.","journal-title":"CNS Spectr"},{"key":"3850_CR45","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00213-018-4874-z","volume":"235","author":"J Kehr","year":"2018","unstructured":"Kehr J, Yoshitake T, Ichinose F, Yoshitake S, Kiss B, Gyertyan I, et al. Effects of cariprazine on extracellular levels of glutamate, GABA, dopamine, noradrenaline and serotonin in the medial prefrontal cortex in the rat phencyclidine model of schizophrenia studied by microdialysis and simultaneous recordings of locomotor activity. Psychopharmacology (Berl). 2018;235:1593\u2013607.","journal-title":"Psychopharmacology (Berl)"},{"key":"3850_CR46","first-page":"391","volume":"15","author":"F Mucci","year":"2025","unstructured":"Mucci F, Arone A, Gurrieri R, Weiss F, Russomanno G, Marazziti D. Third-generation antipsychotics: the quest for the key to neurotrophism. Life (Basel). 2025;15:391.","journal-title":"Life (Basel)"},{"key":"3850_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-023-00375-9","volume":"18","author":"RE Hardy","year":"2023","unstructured":"Hardy RE, Chung I, Yu Y, Loh SHY, Morone N, Soleilhavoup C, et al. The antipsychotic medications aripiprazole, brexpiprazole and cariprazine are off-target respiratory chain complex I inhibitors. Biol Direct. 2023;18:43.","journal-title":"Biol Direct"},{"key":"3850_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13006-015-0053-6","volume":"10","author":"MR Saha","year":"2015","unstructured":"Saha MR, Ryan K, Amir LH. Postpartum women\u2019s use of medicines and breastfeeding practices: a systematic review. Int Breastfeed J. 2015;10:28.","journal-title":"Int Breastfeed J"},{"key":"3850_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2022.100249","volume":"63","author":"M Balog","year":"2022","unstructured":"Balog M, Anderson A, Genaro-Mattos TC, Korade Z, Mirnics K. Individual and simultaneous treatment with antipsychotic aripiprazole and antidepressant trazodone inhibit sterol biosynthesis in the adult brain. J Lipid Res. 2022;63:100249.","journal-title":"J Lipid Res"},{"key":"3850_CR50","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s43440-020-00058-6","volume":"72","author":"M Siwek","year":"2020","unstructured":"Siwek M, Woron J, Gorostowicz A, Wordliczek J. Adverse effects of interactions between antipsychotics and medications used in the treatment of cardiovascular disorders. Pharmacol Rep. 2020;72:350\u20139.","journal-title":"Pharmacol Rep"},{"key":"3850_CR51","unstructured":"Atorvastatin. Drugs and Lactation Database (LactMed(R)). Bethesda (MD)2006."},{"key":"3850_CR52","unstructured":"Rosuvastatin. Drugs and Lactation Database (LactMed(R)). Bethesda (MD)2006."},{"key":"3850_CR53","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2174\/157340411794474784","volume":"7","author":"JO Berle","year":"2011","unstructured":"Berle JO, Spigset O. Antidepressant Use During Breastfeeding. Curr Womens Health Rev. 2011;7:28\u201334.","journal-title":"Curr Womens Health Rev"},{"key":"3850_CR54","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.4088\/JCP.8001tx19c","volume":"70","author":"MP Freeman","year":"2009","unstructured":"Freeman MP. Postpartum depression treatment and breastfeeding. J Clin Psychiatry. 2009;70:e35.","journal-title":"J Clin Psychiatry"},{"key":"3850_CR55","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3390\/ijerph21050551","volume":"21","author":"G Eleftheriou","year":"2024","unstructured":"Eleftheriou G, Zandonella Callegher R, Butera R, De Santis M, Cavaliere AF, Vecchio S, et al. Consensus Panel Recommendations for the Pharmacological Management of Breastfeeding Women with Postpartum Depression. Int J Environ Res Public Health. 2024;21:551.","journal-title":"Int J Environ Res Public Health"},{"key":"3850_CR56","unstructured":"Drugs.com. Cariprazine: Drugs.com; 2025 updated July 7, 2025. https:\/\/www.drugs.com\/cariprazine.html."},{"key":"3850_CR57","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/tpj.2016.48","volume":"16","author":"MR Boland","year":"2016","unstructured":"Boland MR, Tatonetti NP. Investigation of 7-dehydrocholesterol reductase pathway to elucidate off-target prenatal effects of pharmaceuticals: a systematic review. Pharmacogenomics J. 2016;16:411\u201329.","journal-title":"Pharmacogenomics J"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03850-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03850-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03850-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:03:04Z","timestamp":1770822184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03850-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3850"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-03850-9","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}